Neuphoria Therapeutics Inc.
NEUP | NASDAQ
$3.05
-$0.01 (-0.33%)
At close: Oct 30, 2026, 4:00 PM ET
$3.05
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 | Q4 2021 Jun 30, 2021 | Q3 2021 Mar 31, 2021 | Q2 2021 Dec 31, 2020 | Q1 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.17M | n/a | n/a | n/a | -10.47M | 15M | 662.72K | 10.05M | n/a | n/a | n/a | n/a | -66.31K | -66.57K | 66.41K | 66.49K | 2.94M | 2.94M | 84.67K | 84.62K | 161.61K | 161.43K | 302.37K | 302.38K |
Cost of Revenue | 165.68K | 165.7K | 165.79K | 165.79K | 331.14K | 165.43K | 2.81M | 165.71K | 165.69K | 255.18K | 2.99M | 4.8M | 5.37M | 5.39M | 5.38M | 5.39M | 4.52M | 4.52M | 3.48M | 3.48M | 1.86M | 1.85M | 1.03M | 1.03M |
Gross Profit | 1.01M | -165.7K | -165.79K | -165.79K | -10.47M | 15M | 662.72K | -165.71K | -165.69K | -255.18K | -2.99M | -4.8M | 5.31M | 5.33M | -5.32M | -5.32M | -1.58M | -1.58M | -3.39M | -3.39M | -1.69M | -1.69M | -723.88K | -723.89K |
Operating Income | -163.92K | -1.17M | -4.06M | -8.55M | -10.38M | 11.97M | 2.53M | -3.57M | -8.2M | -5.68M | -9.78M | -13.34M | -16.5M | -16.44M | -12.79M | -2.35M | -7.52M | -12.41M | -9.27M | -9.27M | -4.99M | -4.98M | -3.13M | -3.13M |
Interest Income | 170.09K | 186.17K | 167.31K | 142K | 87.05K | 12.74K | 30.62K | 36.1K | 26.33K | 81.03K | 80.19K | 135K | 152.12K | 150.9K | 90.49K | 90.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.94M | -539.86K | 1.83M | -15.04M | -15.01M | 11.18M | -1.93M | -936.97K | 14.26M | -6.55M | -9.86M | -13.43M | -16.22M | -16.22M | -8.16M | -16.19M | -4.4M | -19.35M | -6.57M | -6.57M | -4.39M | -4.39M | -1.52K | 1.22K |
Net Income | -4.9M | -505.06K | 1.86M | -14.99M | -14.85M | 11.26M | -1.94M | -804.79K | -2.69M | 11.66M | 8.47M | 4.9M | -7.95M | -7.86M | -8.11M | -8.12M | -4.35M | -4.35M | -6.53M | -6.52M | -4.35M | -4.34M | -6.36K | -6.36K |
Selling & General & Admin | 1.17M | 2.45M | 3.19M | 2.82M | -1.28M | 1.41M | 4.25M | 2.45M | 3.57M | 2.84M | 5.41M | 5.8M | 4.59M | 4.56M | 2.1M | 2.1M | 1.43M | 1.43M | 2.4M | 2.4M | 1.44M | 1.44M | 1.38M | 1.38M |
Research & Development | n/a | -752.55K | 1.05M | 5.73M | 700.57K | 1.62M | 2.81M | 2.8M | 4.64M | 2.84M | 4.37M | 7.53M | 4.43M | 4.38M | 5.38M | 5.39M | 4.52M | 4.52M | 3.48M | 3.48M | 1.86M | 1.85M | 1.03M | 1.03M |
Other Expenses | n/a | -694.58K | -170.78K | -2.9M | 16.77B | 5.23K | -2.69M | -1.85M | -2.72M | -1.99M | -3.11M | n/a | 2.03M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.17M | 1M | 4.06M | 5.65M | 16.77B | 3.03M | 4.37M | 3.4M | 5.48M | 3.69M | 6.67M | 13.34M | 11.06M | 10.97M | 7.48M | 7.49M | 5.95M | 5.95M | 5.88M | 5.88M | 3.29M | 3.29M | 2.41M | 2.41M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.89K | 1.89K | 6.61K | 6.61K | 471.32K | 470.79K | 239.18K | 239.18K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.12K | -96.76K | 49.53K | n/a | n/a | -55.51K | -55.72K | 55.59K | 55.65K | 47.79K | 47.78K | 83.39K | 83.34K | 297.8K | 297.47K | 338.43K | 338.44K |
Cost & Expenses | 1.34M | 1.17M | 4.06M | 5.65M | 16.77B | 3.03M | 4.37M | 3.57M | 5.48M | 3.69M | 6.67M | 8.54M | 16.43M | 16.37M | 12.86M | 12.88M | 10.47M | 10.46M | 9.36M | 9.35M | 5.15M | 5.14M | 3.44M | 3.44M |
Income Tax Expense | -34.79K | -34.79K | -34.79K | -52.64K | -156.85K | -81.19K | 11.61K | -132.19K | 34.12K | 38.85K | -74.72K | -84.87K | -313.55K | -313.56K | -51.98K | 52.04K | -48.33K | 48.32K | -47.54K | -47.51K | -246.93K | -246.45K | 48.38K | 48.12K |
Shares Outstanding (Basic) | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M | 1.59B | 1.59B | 1.35B | 1.35B | 1.06B | 1.06B | 1B | 1B | 1.01B | 1.01B | 735.25M | 735.25M |
Shares Outstanding (Diluted) | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M | 1.59B | 1.59B | 1.35B | 1.35B | 1.7B | 1.7B | 1B | 1B | 1.01B | 1.01B | 735.25M | 735.25M |
EPS (Basic) | -0.91 | -0.09 | 0.41 | -6.67 | -4.65 | 6.55 | -0.01 | 0 | 0 | -0.03 | -0.05 | -0.04 | -0.01 | 0 | -0.01 | -0.01 | 0 | 0 | -0.01 | -0.01 | 0 | 0 | n/a | n/a |
EPS (Diluted) | -0.91 | -0.09 | 0.41 | -6.67 | -4.65 | 6.55 | -0.01 | 0 | 0 | -0.03 | -0.05 | -0.04 | -0.01 | 0 | -0.01 | -0.01 | 0 | 0 | -0.01 | -0.01 | 0 | 0 | n/a | n/a |
EBITDA | 1.77K | -1M | -3.27M | -8.3M | -10.16M | 12.14M | -5.22M | -5.01M | -7.95M | -5.28M | -9.22M | -12.93M | -8.53M | -8.46M | -7.18M | -7.19M | -2.77M | -2.77M | -5.56M | -5.55M | -2.85M | -2.72M | -1.7M | -1.7M |
EBIT | -163.92K | -1.17M | -3.51M | -8.55M | -10.38M | 11.97M | 2.53M | -5.25M | -8.2M | -5.68M | -9.57M | -8.54M | -8.78M | -8.69M | -7.41M | -7.42M | -3.01M | -3.01M | -5.79M | -5.79M | -3.08M | -3.08M | -2.06M | -2.06M |
Depreciation & Amortization | 165.68K | 165.7K | 248.37K | 250.83K | 218.5K | 165.43K | 268.35K | 244.06K | 248.05K | 392.96K | 355.85K | 404.7K | 248.81K | 231.69K | 231.12K | 231.41K | 230.93K | 234.32K | 234.48K | 234.35K | 234.67K | 354.87K | 354.84K | 354.84K |
Add to Watchlist
Select watchlists to add or remove NEUP